Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    May 2018
  1. CHEN BB, Lu YS, Yu CW, Lin CH, et al
    Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5448.
    PubMed     Text format     Abstract available


  2. VAN DER VELDEN BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, et al
    Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5470.
    PubMed     Text format     Abstract available


    April 2018
  3. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    PubMed     Text format     Abstract available


  4. KIM WH, Cho N, Kim YS, Yi A, et al
    Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Eur Radiol. 2018 Apr 6. pii: 10.1007/s00330-017-5293.
    PubMed     Text format     Abstract available


    March 2018
  5. SANABRIA SJ, Goksel O, Martini K, Forte S, et al
    Breast-density assessment with hand-held ultrasound: A novel biomarker to assess breast cancer risk and to tailor screening?
    Eur Radiol. 2018 Mar 19. pii: 10.1007/s00330-017-5287.
    PubMed     Text format     Abstract available


  6. KIM SY, Shin J, Kim DH, Kim EK, et al
    Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging.
    Eur Radiol. 2018 Mar 6. pii: 10.1007/s00330-017-5291.
    PubMed     Text format     Abstract available


    January 2018
  7. KIM SY, Cho N, Shin SU, Lee HB, et al
    Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Eur Radiol. 2018 Jan 29. pii: 10.1007/s00330-017-5251.
    PubMed     Text format     Abstract available


  8. LI X, Gao H, Chen Z, Zhang L, et al
    Diagnosis of breast cancer based on microcalcifications using grating-based phase contrast CT.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5158.
    PubMed     Text format     Abstract available


  9. HORVAT JV, Durando M, Milans S, Patil S, et al
    Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.
    Eur Radiol. 2018 Jan 12. pii: 10.1007/s00330-017-5202.
    PubMed     Text format     Abstract available


    December 2017
  10. RODRIGUEZ-RUIZ A, Gubern-Merida A, Imhof-Tas M, Lardenoije S, et al
    One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
    Eur Radiol. 2017 Dec 11. pii: 10.1007/s00330-017-5167.
    PubMed     Text format     Abstract available


    November 2017
  11. MOSHINA N, Roman M, Waade GG, Sebuodegard S, et al
    Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Eur Radiol. 2017 Nov 2. doi: 10.1007/s00330-017-5104.
    PubMed     Text format     Abstract available


    October 2017
  12. ZHAO J, Zhang J, Zhu QL, Jiang YX, et al
    The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study.
    Eur Radiol. 2017 Oct 20. doi: 10.1007/s00330-017-5089.
    PubMed     Text format     Abstract available


  13. GIROMETTI R, Zanotel M, Londero V, Linda A, et al
    Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.
    Eur Radiol. 2017 Oct 10. doi: 10.1007/s00330-017-5074.
    PubMed     Text format     Abstract available


    August 2017
  14. DONG Y, Feng Q, Yang W, Lu Z, et al
    Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.
    Eur Radiol. 2017 Aug 21. doi: 10.1007/s00330-017-5005.
    PubMed     Text format     Abstract available


    July 2017
  15. WIENBECK S, Uhlig J, Luftner-Nagel S, Zapf A, et al
    The role of cone-beam breast-CT for breast cancer detection relative to breast density.
    Eur Radiol. 2017 Jul 4. doi: 10.1007/s00330-017-4911.
    PubMed     Text format     Abstract available


    June 2017
  16. SONG SE, Park EK, Cho KR, Seo BK, et al
    Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
    Eur Radiol. 2017 Jun 7. doi: 10.1007/s00330-017-4898.
    PubMed     Text format     Abstract available


    May 2017
  17. KRAMMER J, Price ER, Jochelson MS, Watson E, et al
    Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins.
    Eur Radiol. 2017 May 31. doi: 10.1007/s00330-017-4823.
    PubMed     Text format     Abstract available


  18. HENDERSON S, Purdie C, Michie C, Evans A, et al
    Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4850.
    PubMed     Text format     Abstract available


  19. TIAN F, Shen G, Deng Y, Diao W, et al
    The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review.
    Eur Radiol. 2017 May 5. doi: 10.1007/s00330-017-4831.
    PubMed     Text format     Abstract available


    March 2017
  20. TIMMERMANS L, Bleyen L, Bacher K, Van Herck K, et al
    Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
    Eur Radiol. 2017 Mar 13. doi: 10.1007/s00330-017-4757.
    PubMed     Text format     Abstract available


    January 2017
  21. GWEON HM, Cho N, Kim SY, Koo HR, et al
    Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients.
    Eur Radiol. 2017 Jan 12. doi: 10.1007/s00330-016-4721.
    PubMed     Text format     Abstract available


  22. MAURI G, Sconfienza LM, Pescatori LC, Fedeli MP, et al
    Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.
    Eur Radiol. 2017 Jan 3. doi: 10.1007/s00330-016-4668.
    PubMed     Text format     Abstract available


    December 2016
  23. GARCIA-VELLOSO MJ, Ribelles MJ, Rodriguez M, Fernandez-Montero A, et al
    MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
    Eur Radiol. 2016 Dec 21. doi: 10.1007/s00330-016-4685.
    PubMed     Text format     Abstract available


    November 2016
  24. SARDANELLI F, Aase HS, Alvarez M, Azavedo E, et al
    Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, Franc
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  25. HAMMER MM, Mortani Barbosa EJ Jr
    Predictive factors for malignancy in incidental pulmonary nodules detected in breast cancer patients at baseline CT.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  26. BEDAIR R, Priest AN, Patterson AJ, McLean MA, et al
    Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  27. GRIMM LJ, Johnson DY, Johnson KS, Baker JA, et al
    Suspicious breast calcifications undergoing stereotactic biopsy in women ages 70 and over: Breast cancer incidence by BI-RADS descriptors.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  28. MINARIKOVA L, Bogner W, Pinker K, Valkovic L, et al
    Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


  29. BITENCOURT AG, Lima EN, Macedo BR, Conrado JL, et al
    Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Eur Radiol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  30. DRISIS S, Metens T, Ignatiadis M, Stathopoulos K, et al
    Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy.
    Eur Radiol. 2016;26:1474-84.
    PubMed     Text format     Abstract available


  31. GRUBER S, Minarikova L, Pinker K, Zaric O, et al
    Diffusion-weighted imaging of breast tumours at 3 Tesla and 7 Tesla: a comparison.
    Eur Radiol. 2016;26:1466-73.
    PubMed     Text format     Abstract available


  32. ROMINGER M, Berg D, Frauenfelder T, Ramaswamy A, et al
    Which factors influence MRI-pathology concordance of tumour size measurements in breast cancer?
    Eur Radiol. 2016;26:1457-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: